2023-02-012024-02-292024-02-29false14632502THE INDUSTRIAL PHARMACIST LTD2024-09-0421200iso4217:GBPxbrli:pure146325022023-02-01146325022024-02-29146325022023-02-012024-02-29146325022023-01-31146325022023-01-31146325022023-01-312023-01-3114632502bus:SmallEntities2023-02-012024-02-2914632502bus:AuditExempt-NoAccountantsReport2023-02-012024-02-2914632502bus:AbridgedAccounts2023-02-012024-02-2914632502bus:PrivateLimitedCompanyLtd2023-02-012024-02-2914632502core:WithinOneYear2024-02-2914632502core:AfterOneYear2024-02-2914632502core:WithinOneYear2023-01-3114632502core:AfterOneYear2023-01-3114632502core:ShareCapital2024-02-2914632502core:SharePremium2024-02-2914632502core:RevaluationReserve2024-02-2914632502core:OtherReservesSubtotal2024-02-2914632502core:RetainedEarningsAccumulatedLosses2024-02-2914632502core:ShareCapital2023-01-3114632502core:SharePremium2023-01-3114632502core:RevaluationReserve2023-01-3114632502core:OtherReservesSubtotal2023-01-3114632502core:RetainedEarningsAccumulatedLosses2023-01-3114632502core:LandBuildings2024-02-2914632502core:PlantMachinery2024-02-2914632502core:Vehicles2024-02-2914632502core:FurnitureFittings2024-02-2914632502core:OfficeEquipment2024-02-2914632502core:NetGoodwill2024-02-2914632502core:IntangibleAssetsOtherThanGoodwill2024-02-2914632502core:ListedExchangeTraded2024-02-2914632502core:UnlistedNon-exchangeTraded2024-02-2914632502core:LandBuildings2023-01-3114632502core:PlantMachinery2023-01-3114632502core:Vehicles2023-01-3114632502core:FurnitureFittings2023-01-3114632502core:OfficeEquipment2023-01-3114632502core:NetGoodwill2023-01-3114632502core:IntangibleAssetsOtherThanGoodwill2023-01-3114632502core:ListedExchangeTraded2023-01-3114632502core:UnlistedNon-exchangeTraded2023-01-3114632502core:LandBuildings2023-02-012024-02-2914632502core:PlantMachinery2023-02-012024-02-2914632502core:Vehicles2023-02-012024-02-2914632502core:FurnitureFittings2023-02-012024-02-2914632502core:OfficeEquipment2023-02-012024-02-2914632502core:NetGoodwill2023-02-012024-02-2914632502core:IntangibleAssetsOtherThanGoodwill2023-02-012024-02-2914632502core:ListedExchangeTraded2023-02-012024-02-2914632502core:UnlistedNon-exchangeTraded2023-02-012024-02-2914632502core:MoreThanFiveYears2023-02-012024-02-2914632502core:Non-currentFinancialInstruments2024-02-2914632502core:Non-currentFinancialInstruments2023-01-3114632502dpl:CostSales2023-02-012024-02-2914632502dpl:DistributionCosts2023-02-012024-02-2914632502core:LandBuildings2023-02-012024-02-2914632502core:PlantMachinery2023-02-012024-02-2914632502core:Vehicles2023-02-012024-02-2914632502core:FurnitureFittings2023-02-012024-02-2914632502core:OfficeEquipment2023-02-012024-02-2914632502dpl:AdministrativeExpenses2023-02-012024-02-2914632502core:NetGoodwill2023-02-012024-02-2914632502core:IntangibleAssetsOtherThanGoodwill2023-02-012024-02-2914632502dpl:GroupUndertakings2023-02-012024-02-2914632502dpl:ParticipatingInterests2023-02-012024-02-2914632502dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-012024-02-2914632502core:ListedExchangeTraded2023-02-012024-02-2914632502dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-012024-02-2914632502core:UnlistedNon-exchangeTraded2023-02-012024-02-2914632502dpl:CostSales2023-01-312023-01-3114632502dpl:DistributionCosts2023-01-312023-01-3114632502core:LandBuildings2023-01-312023-01-3114632502core:PlantMachinery2023-01-312023-01-3114632502core:Vehicles2023-01-312023-01-3114632502core:FurnitureFittings2023-01-312023-01-3114632502core:OfficeEquipment2023-01-312023-01-3114632502dpl:AdministrativeExpenses2023-01-312023-01-3114632502core:NetGoodwill2023-01-312023-01-3114632502core:IntangibleAssetsOtherThanGoodwill2023-01-312023-01-3114632502dpl:GroupUndertakings2023-01-312023-01-3114632502dpl:ParticipatingInterests2023-01-312023-01-3114632502dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-312023-01-3114632502core:ListedExchangeTraded2023-01-312023-01-3114632502dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-312023-01-3114632502core:UnlistedNon-exchangeTraded2023-01-312023-01-3114632502core:NetGoodwill2024-02-2914632502core:IntangibleAssetsOtherThanGoodwill2024-02-2914632502core:LandBuildings2024-02-2914632502core:PlantMachinery2024-02-2914632502core:Vehicles2024-02-2914632502core:FurnitureFittings2024-02-2914632502core:OfficeEquipment2024-02-2914632502core:AfterOneYear2024-02-2914632502core:WithinOneYear2024-02-2914632502core:ListedExchangeTraded2024-02-2914632502core:UnlistedNon-exchangeTraded2024-02-2914632502core:ShareCapital2024-02-2914632502core:SharePremium2024-02-2914632502core:RevaluationReserve2024-02-2914632502core:OtherReservesSubtotal2024-02-2914632502core:RetainedEarningsAccumulatedLosses2024-02-2914632502core:NetGoodwill2023-01-3114632502core:IntangibleAssetsOtherThanGoodwill2023-01-3114632502core:LandBuildings2023-01-3114632502core:PlantMachinery2023-01-3114632502core:Vehicles2023-01-3114632502core:FurnitureFittings2023-01-3114632502core:OfficeEquipment2023-01-3114632502core:AfterOneYear2023-01-3114632502core:WithinOneYear2023-01-3114632502core:ListedExchangeTraded2023-01-3114632502core:UnlistedNon-exchangeTraded2023-01-3114632502core:ShareCapital2023-01-3114632502core:SharePremium2023-01-3114632502core:RevaluationReserve2023-01-3114632502core:OtherReservesSubtotal2023-01-3114632502core:RetainedEarningsAccumulatedLosses2023-01-3114632502core:NetGoodwill2023-01-3114632502core:IntangibleAssetsOtherThanGoodwill2023-01-3114632502core:LandBuildings2023-01-3114632502core:PlantMachinery2023-01-3114632502core:Vehicles2023-01-3114632502core:FurnitureFittings2023-01-3114632502core:OfficeEquipment2023-01-3114632502core:AfterOneYear2023-01-3114632502core:WithinOneYear2023-01-3114632502core:ListedExchangeTraded2023-01-3114632502core:UnlistedNon-exchangeTraded2023-01-3114632502core:ShareCapital2023-01-3114632502core:SharePremium2023-01-3114632502core:RevaluationReserve2023-01-3114632502core:OtherReservesSubtotal2023-01-3114632502core:RetainedEarningsAccumulatedLosses2023-01-3114632502core:AfterOneYear2023-02-012024-02-2914632502core:WithinOneYear2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:CostValuation2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-02-012024-02-2914632502core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2914632502core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2914632502core:Non-currentFinancialInstrumentscore:CostValuation2023-01-3114632502core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-3114632502core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-3114632502bus:Director12023-02-012024-02-29

THE INDUSTRIAL PHARMACIST LTD

Registered Number
14632502
(England and Wales)

Unaudited Financial Statements for the Period ended
29 February 2024

THE INDUSTRIAL PHARMACIST LTD
Company Information
for the period from 1 February 2023 to 29 February 2024

Director

AJALA, Moriam

Registered Address

320 City Road
London
EC1V 2NZ

Registered Number

14632502 (England and Wales)
THE INDUSTRIAL PHARMACIST LTD
Balance Sheet as at
29 February 2024

Notes

2024

£

£

Current assets
Debtors20,000
Cash at bank and on hand10,203
30,203
Creditors amounts falling due within one year(16,433)
Net current assets (liabilities)13,770
Total assets less current liabilities13,770
Net assets13,770
Capital and reserves
Called up share capital100
Profit and loss account13,670
Shareholders' funds13,770
The financial statements were approved and authorised for issue by the Director on 4 September 2024, and are signed on its behalf by:
AJALA, Moriam
Director
Registered Company No. 14632502
THE INDUSTRIAL PHARMACIST LTD
Notes to the Financial Statements
for the period ended 29 February 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

2024
Average number of employees during the year1